What's Happening?
The U.S. Food and Drug Administration (FDA) has not cleared or approved whole-body cryotherapy devices to treat any medical condition. This means that while cryotherapy is popular in wellness and recovery studios, particularly among athletes, it should
be regarded as a wellness service rather than a medical treatment. Whole-body cryotherapy sessions typically involve standing in a chamber where very cold, dry air, often nitrogen-cooled or electric, surrounds the body at temperatures ranging from approximately -200°F to -300°F for about two to three minutes. Participants wear protective gear such as gloves, socks, and dry clothing to shield extremities, and sessions are staff-timed. The dry nature of the cold air means individuals do not get wet, which many find more tolerable than cold water at warmer temperatures.
Why It's Important?
The FDA's stance on whole-body cryotherapy is significant for consumers and the wellness industry in the U.S. By not approving these devices for medical conditions, the FDA is signaling that any claims of medical benefits are unsubstantiated from a regulatory perspective. This distinction is crucial for consumer safety, as it prevents facilities from marketing cryotherapy as a cure or treatment for illnesses without scientific backing. For businesses offering cryotherapy, it underscores the need to accurately represent their services as wellness-oriented rather than medical. This regulatory clarity helps manage public expectations and ensures that individuals seeking medical treatment for specific conditions will pursue FDA-approved therapies, rather than relying on unproven wellness practices.
What's Next?
Given the FDA's current position, it is unlikely that whole-body cryotherapy will be recognized as a medical treatment in the near future without substantial clinical trials and evidence demonstrating its efficacy and safety for specific conditions. The wellness industry will likely continue to offer cryotherapy as a recovery and wellness service, emphasizing its perceived benefits for athletic recovery, muscle soreness, and general well-being, rather than medical treatment. Consumers should remain informed about the FDA's guidelines and consult healthcare professionals for medical conditions, understanding that cryotherapy is not a substitute for conventional medical care. The market for cryotherapy may continue to grow within the wellness sector, driven by demand for non-invasive recovery methods.
Beyond the Headlines
The classification of whole-body cryotherapy as a wellness service by the FDA highlights a broader trend in the U.S. where various alternative and complementary therapies operate in a regulatory gray area. This situation raises questions about consumer protection, the marketing of health-related services, and the distinction between wellness and medical treatment. The lack of FDA approval means that the long-term effects and potential risks of whole-body cryotherapy, especially for vulnerable populations, may not be fully understood or regulated. This scenario encourages a critical approach to health and wellness claims, urging consumers to prioritize evidence-based practices and regulatory oversight when making decisions about their health.













